![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 6Biovail Corporation
Reset all filters
01 32240329
02 32241611
Reset all filters
01 6Dexmethylphenidate
Reset all filters
01 6Tablet
Reset all filters
01 32018-06-11
02 32018-06-22
Patent Expiration Date : 2018-06-22
Date Granted : 2004-08-17
Brand Name : ATTENADE
Patent Number : 2241611
Filing Date : 1998-06-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-22
Date Granted : 2004-08-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2018-06-11
Date Granted : 2004-12-28
Brand Name : ATTENADE
Patent Number : 2240329
Filing Date : 1998-06-11
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-11
Date Granted : 2004-12-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2018-06-22
Date Granted : 2004-08-17
Brand Name : ATTENADE
Patent Number : 2241611
Filing Date : 1998-06-22
Strength per Unit : 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-22
Date Granted : 2004-08-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2018-06-11
Date Granted : 2004-12-28
Brand Name : ATTENADE
Patent Number : 2240329
Filing Date : 1998-06-11
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-11
Date Granted : 2004-12-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2018-06-22
Date Granted : 2004-08-17
Brand Name : ATTENADE
Patent Number : 2241611
Filing Date : 1998-06-22
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-22
Date Granted : 2004-08-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2018-06-11
Date Granted : 2004-12-28
Brand Name : ATTENADE
Patent Number : 2240329
Filing Date : 1998-06-11
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-06-11
Date Granted : 2004-12-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?